GDH-PQQ (glucose dehydrogenase pyrroloquinoline quinone) Glucose Monitoring Technology
MedSun: Newsletter #40, September 2009

Please see this month's FDA MedWatch Safety Alert which notifies healthcare professionals of the possibility of falsely elevated blood glucose results when using GDH-PQQ glucose test strips on patients who are receiving therapeutic products containing certain non-glucose sugars.

Additional Information:

FDA MedWatch Safety Alert. GDH-PQQ (glucose dehydrogenase pyrroloquinoline quinone) Glucose Monitoring Technology. August 13, 2009.
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm177295.htm

MedSun Newsletter. September 2009. GDH-PQQ (glucose dehydrogenase pyrroloquinoline quinone) Glucose Monitoring Technology.
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/medsun/news/newsletter.cfm?news=40#4


MedSun Newsletters are available at www.fda.gov/cdrh/medsun